SCHEMBL19293792

SCHEMBL19293792

c1ccc(-c2cc(-c3cccc(-c4ccc(C5(c6ccccc6)c6ccccc6-c6ccccc65)cc4)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.47
▸ KMT2A Q03164 8/20 0.47
▸ MAPT P10636 7/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ HPGD P15428 5/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ LMNA P02545 3/20 0.47
▸ GLA P06280 1/20 0.47
▸ NTSR1 P30989 1/20 0.45
▸ OPRK1 P41145 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PDK2 Q15119 2/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAOB P27338 5/20 0.39
▸ MAOA P21397 3/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19293806 1.00 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24264504 0.97 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22308599 0.96 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22308597 0.96 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19885879 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008458 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25121668 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008847 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22308600 0.96 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008651 0.96 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10516113-B2 Organic compound, organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2019-12-24 — — US disclosed
US-20170250349-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-08-31 — — US disclosed
US-20170250349-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250349-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OCIAD1, OXER1, OR10J3 MEN1 2223/4885KMT2A 4151/4885MAPT 2377/4885
US-10516113-B2 Organic compound, organic optoelectric device and display device OCIAD1, OXER1, OR10J3 MEN1 2223/4885KMT2A 4151/4885MAPT 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback